These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21958736)

  • 1. Identification of new antimalarial leads by use of virtual screening against cytochrome bc₁.
    Rodrigues T; Moreira R; Gut J; Rosenthal PJ; O Neill PM; Biagini GA; Lopes F; dos Santos DJ; Guedes RC
    Bioorg Med Chem; 2011 Nov; 19(21):6302-8. PubMed ID: 21958736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acridinediones: selective and potent inhibitors of the malaria parasite mitochondrial bc1 complex.
    Biagini GA; Fisher N; Berry N; Stocks PA; Meunier B; Williams DP; Bonar-Law R; Bray PG; Owen A; O'Neill PM; Ward SA
    Mol Pharmacol; 2008 May; 73(5):1347-55. PubMed ID: 18319379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of plasmepsin inhibitors as selective anti-malarial agents using ligand based drug design.
    McKay PB; Peters MB; Carta G; Flood CT; Dempsey E; Bell A; Berry C; Lloyd DG; Fayne D
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3335-41. PubMed ID: 21531557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural insights into the Plasmodium falciparum histone deacetylase 1 (PfHDAC-1): A novel target for the development of antimalarial therapy.
    Mukherjee P; Pradhan A; Shah F; Tekwani BL; Avery MA
    Bioorg Med Chem; 2008 May; 16(9):5254-65. PubMed ID: 18362073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting Plasmodium cytochrome bc1: a complex issue.
    Barton V; Fisher N; Biagini GA; Ward SA; O'Neill PM
    Curr Opin Chem Biol; 2010 Aug; 14(4):440-6. PubMed ID: 20570550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploration of 4(1H)-pyridones as a novel family of potent antimalarial inhibitors of the plasmodial cytochrome bc1.
    Bueno JM; Herreros E; Angulo-Barturen I; Ferrer S; Fiandor JM; Gamo FJ; Gargallo-Viola D; Derimanov G
    Future Med Chem; 2012 Dec; 4(18):2311-23. PubMed ID: 23234553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of benzophenone-based farnesyltransferase inhibitors as novel antimalarials.
    Kohring K; Wiesner J; Altenkämper M; Sakowski J; Silber K; Hillebrecht A; Haebel P; Dahse HM; Ortmann R; Jomaa H; Klebe G; Schlitzer M
    ChemMedChem; 2008 Aug; 3(8):1217-31. PubMed ID: 18470859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel malarial cysteine protease inhibitors using structure-based virtual screening of a focused cysteine protease inhibitor library.
    Shah F; Mukherjee P; Gut J; Legac J; Rosenthal PJ; Tekwani BL; Avery MA
    J Chem Inf Model; 2011 Apr; 51(4):852-64. PubMed ID: 21428453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A drug-selected Plasmodium falciparum lacking the need for conventional electron transport.
    Smilkstein MJ; Forquer I; Kanazawa A; Kelly JX; Winter RW; Hinrichs DJ; Kramer DM; Riscoe MK
    Mol Biochem Parasitol; 2008 May; 159(1):64-8. PubMed ID: 18308406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimalarial histone deacetylase inhibitors containing cinnamate or NSAID components.
    Wheatley NC; Andrews KT; Tran TL; Lucke AJ; Reid RC; Fairlie DP
    Bioorg Med Chem Lett; 2010 Dec; 20(23):7080-4. PubMed ID: 20951583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel inhibitors of the Plasmodium falciparum electron transport chain.
    Stocks PA; Barton V; Antoine T; Biagini GA; Ward SA; O'Neill PM
    Parasitology; 2014 Jan; 141(1):50-65. PubMed ID: 24401337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Silico Exploration for New Antimalarials: Arylsulfonyloxy Acetimidamides as Prospective Agents.
    Verma S; Debnath U; Agarwal P; Srivastava K; Prabhakar YS
    J Chem Inf Model; 2015 Aug; 55(8):1708-19. PubMed ID: 26237069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antimalarial interactions between mefloquine and cytochrome P450 inhibitors.
    Wisedpanichkij R; Chaijaroenkul W; Sangsuwan P; Tantisawat J; Boonprasert K; Na-Bangchang K
    Acta Trop; 2009 Oct; 112(1):12-5. PubMed ID: 19497287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and structure-activity relationships of (1H-pyridin-4-ylidene)amines as potential antimalarials.
    Rodrigues T; Guedes RC; dos Santos DJ; Carrasco M; Gut J; Rosenthal PJ; Moreira R; Lopes F
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3476-80. PubMed ID: 19467600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and validation of tetracyclic benzothiazepines as Plasmodium falciparum cytochrome bc1 inhibitors.
    Dong CK; Urgaonkar S; Cortese JF; Gamo FJ; Garcia-Bustos JF; Lafuente MJ; Patel V; Ross L; Coleman BI; Derbyshire ER; Clish CB; Serrano AE; Cromwell M; Barker RH; Dvorin JD; Duraisingh MT; Wirth DF; Clardy J; Mazitschek R
    Chem Biol; 2011 Dec; 18(12):1602-10. PubMed ID: 22195562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico identification of novel inhibitors against Plasmodium falciparum dihydroorate dehydrogenase.
    Wadood A; Ulhaq ZU
    J Mol Graph Model; 2013 Mar; 40():40-7. PubMed ID: 23353582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shape- and chemical feature-based 3D-pharmacophore model generation and virtual screening: identification of potential leads for P. falciparum DHFR enzyme inhibition.
    Adane L; Patel DS; Bharatam PV
    Chem Biol Drug Des; 2010 Jan; 75(1):115-26. PubMed ID: 19895504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of Plasmodium falciparum to glutamate dehydrogenase inhibitors--a possible new antimalarial target.
    Aparicio IM; Marín-Menéndez A; Bell A; Engel PC
    Mol Biochem Parasitol; 2010 Aug; 172(2):152-5. PubMed ID: 20399810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A plant-derived morphinan as a novel lead compound active against malaria liver stages.
    Carraz M; Jossang A; Franetich JF; Siau A; Ciceron L; Hannoun L; Sauerwein R; Frappier F; Rasoanaivo P; Snounou G; Mazier D
    PLoS Med; 2006 Dec; 3(12):e513. PubMed ID: 17194195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.